SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes

Clinical trial NCT07614230 · RECRUITING

Trial details

NCT number: NCT07614230
Sponsor: Junjie Yang
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)Coronary Artery Disease Atherosclerosis

Start date: 2026-01-01
Primary completion: 2027-06-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.